We need a mind-shift in how medicine spending is weighed

The State’s pricing deal with the pharmaceutical industry ends this year, and the funding of innovation must become a priority, if patients here are to have the early access that patients elsewhere in western Europe have, says Bernard Mallee

For 50 years, Ireland’s pharmaceutical industry has been attracting major investments in manufacturing and research, creating tens of thousands of jobs and supplying medicines for complex illnesses.